N. Paksoy Et Al. , "Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma.," JOURNAL OF CLINICAL ONCOLOGY , vol.39, no.15, 2021
Paksoy, N. Et Al. 2021. Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma.. JOURNAL OF CLINICAL ONCOLOGY , vol.39, no.15 .
Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M., (2021). Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma.. JOURNAL OF CLINICAL ONCOLOGY , vol.39, no.15.
Paksoy, Nail Et Al. "Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma.," JOURNAL OF CLINICAL ONCOLOGY , vol.39, no.15, 2021
Paksoy, Nail Et Al. "Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma.." JOURNAL OF CLINICAL ONCOLOGY , vol.39, no.15, 2021
Paksoy, N. Et Al. (2021) . "Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma.." JOURNAL OF CLINICAL ONCOLOGY , vol.39, no.15.
@article{article, author={Nail Paksoy Et Al. }, title={Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma.}, journal={JOURNAL OF CLINICAL ONCOLOGY}, year=2021}